Status:
UNKNOWN
A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)
Lead Sponsor:
Shenyang Northern Hospital
Conditions:
Adrenergic Beta-Antagonists
Stable Angina Pectoris
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The present study aims to enhance the adherence of beta-blockers by Patient Support Tool through a smart phone application and a wristband, subsequently reduce the risk of angina attacks in patients w...
Detailed Description
To control heart rate in terms of guidelines in patients with stable angina pectoris reduces risk of cardiovascular events, rehospitalization, and death effectively. Using beta blockers is an efficien...
Eligibility Criteria
Inclusion
- Aged 18-70 years;
- Stable angina pectoris;
- Indicated for beta blockers;
- HR ≥ 60bpm;
- Patient must have a smart phone that is compatible with the Patient support tool at their disposal and are comfortable with using of interactive smart phone applications. The required specification for the phone will be determined after completed testing;
- Ability to read, understand and write Chinese;
- Beta-blockers naïve or with no Beta-blocker use during the last 1 month.
Exclusion
- Previous myocardial infarction during the recent 1 year;
- Cardiac shock or unstable heart failure (NYHA III);
- SBP\<100 mmHg;
- Sick sinus syndrome;
- II-III degree atrioventricular block;
- Existing contraindication for Beta-blockers or allergic to beta-blockers;
- Participation in another clinical study with a beta blocker during the last 3 months;
- Inability to sign the informed consent form;
- Females during pregnancy and lactation and women of child bearing potential planning to be pregnant within 24 weeks.;
- Patients who withdraw from this study for any reason cannot re-enter the study;
- Life expectancy \< 1 year;
- Severe asthma or COPD;
- Severe peripheral vascular disease;
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
432 Patients enrolled
Trial Details
Trial ID
NCT03794713
Start Date
April 1 2019
End Date
September 1 2020
Last Update
January 7 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.